Statin therapy and SAR-COV-2: an available and potential therapy?
作者信息
Abdel-Latif Rania G, Mohammed Shaban, Elgendy Islam Y
机构信息
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University, El-Minia, Egypt.
Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar.
出版信息
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):333-334. doi: 10.1093/ehjcvp/pvaa050.
Abstract
摘要
相似文献
1
Statin therapy and SAR-COV-2: an available and potential therapy?他汀类药物治疗与新型冠状病毒2：一种可行且有潜力的治疗方法？
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):333-334. doi: 10.1093/ehjcvp/pvaa050.
2
Statins in coronavirus outbreak: It's time for experimental and clinical studies.冠状病毒爆发中的他汀类药物：是时候进行实验和临床研究了。
Pharmacol Res. 2020 Jun;156:104803. doi: 10.1016/j.phrs.2020.104803. Epub 2020 Apr 11.
3
Considerations for Statin Therapy in Patients with COVID-19.新型冠状病毒肺炎患者他汀类药物治疗的考量因素
Pharmacotherapy. 2020 May;40(5):484-486. doi: 10.1002/phar.2397. Epub 2020 May 4.
4
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.伊维菌素可能是一种对晚期新冠肺炎有临床实用价值的抗炎药。
Open Heart. 2020 Sep;7(2). doi: 10.1136/openhrt-2020-001350.
5
[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].[严重急性呼吸综合征冠状病毒2（SARS-CoV-2）：我们应该针对病毒、细胞还是疾病？]
Virologie (Montrouge). 2020 Jun 1;24(3):135-141. doi: 10.1684/vir.2020.0843.
6
Surviving COVID-19: A disease tolerance perspective.从疾病耐受性角度看新冠病毒感染后的生存情况
Sci Adv. 2020 Apr 29;6(18):eabc1518. doi: 10.1126/sciadv.abc1518. eCollection 2020 May.
7
Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus.营养保健品有潜力增强对包括流感病毒和冠状病毒在内的RNA病毒的1型干扰素反应。
Prog Cardiovasc Dis. 2020 May-Jun;63(3):383-385. doi: 10.1016/j.pcad.2020.02.007. Epub 2020 Feb 12.
8
Is the type of diabetes treatment relevant to outcome of COVID-19?糖尿病治疗类型与新型冠状病毒肺炎的预后有关吗？
J Diabetes. 2020 Jul;12(7):486-487. doi: 10.1111/1753-0407.13047.
9
Covid-19: Time for a paradigm change.新冠疫情：是时候进行范式转变了。
Rev Med Virol. 2020 Sep;30(5):e2134. doi: 10.1002/rmv.2134. Epub 2020 Jul 3.
10
Sofosbuvir for COVID-19 infection: A potential candidate.索磷布韦用于治疗新型冠状病毒肺炎感染：一个潜在的候选药物。
Indian J Pharmacol. 2020 May-Jun;52(3):232-233. doi: 10.4103/ijp.IJP_675_20. Epub 2020 Aug 4.
引用本文的文献
1
Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction.树突状细胞内胆固醇蓄积逆转慢性乙型肝炎病毒感染诱导的功能障碍。
Cell Mol Immunol. 2022 Dec;19(12):1347-1360. doi: 10.1038/s41423-022-00939-1. Epub 2022 Nov 11.
本文引用的文献
1
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
2
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).COVID-19 患者的致命结局对心血管的影响。
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
3
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
4
Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.他汀类药物通过干扰糖蛋白加工来抑制埃博拉病毒感染性。
mBio. 2018 May 1;9(3):e00660-18. doi: 10.1128/mBio.00660-18.
5
Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting.冠状动脉旁路移植术患者的围手术期他汀类药物治疗
Ann Thorac Surg. 2016 Feb;101(2):818-25. doi: 10.1016/j.athoracsur.2015.09.070.
6
IL-10-producing B cells involved in the pathogenesis of Coxsackie virus B3-induced acute viral myocarditis.产生白细胞介素-10的B细胞参与柯萨奇病毒B3诱导的急性病毒性心肌炎的发病机制。
Int J Clin Exp Pathol. 2015 Jan 1;8(1):830-5. eCollection 2015.
7
Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats.瑞舒伐他汀对大鼠血管球囊损伤后血管紧张素转换酶 2 表达的影响。
J Geriatr Cardiol. 2013 Jun;10(2):151-8. doi: 10.3969/j.issn.1671-5411.2013.02.009.
8
Statins reduce the expression of proinflammatory cytokines in influenza A virus infected CrFK cells.他汀类药物可降低甲型流感病毒感染的CrFK细胞中促炎细胞因子的表达。
Acta Virol. 2012;56(4):353-5. doi: 10.4149/av_2012_04_353.
9
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins.流感和慢性阻塞性肺疾病死亡率的保护作用是他汀类药物的多效性、剂量依赖性效应。
Chest. 2007 Apr;131(4):1006-12. doi: 10.1378/chest.06-1997.
10
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.血管紧张素转换酶2（ACE2）在严重急性呼吸综合征冠状病毒诱导的肺损伤中的关键作用。
Nat Med. 2005 Aug;11(8):875-9. doi: 10.1038/nm1267. Epub 2005 Jul 10.
Zotero 插件